140 related articles for article (PubMed ID: 35684974)
1. Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.
Miller MJ; Himschoot A; Fitch N; Jawalkar S; Freeman D; Hilton C; Berney K; Guy GP; Benoit TJ; Clarke KEN; Busch MP; Opsomer JD; Stramer SL; Hall AJ; Gundlapalli AV; MacNeil A; McCord R; Sunshine G; Howard-Williams M; Dunphy C; Jones JM
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S264-S270. PubMed ID: 35684974
[TBL] [Abstract][Full Text] [Related]
2. Trends in Percentages of the US Population Covered by State-Issued COVID-19 Nonpharmaceutical Interventions, March 1, 2020-August 15, 2021.
Joo H; Howard-Williams M; McCord RF; Sunshine G; Fuller JA; Maskery BA
J Public Health Manag Pract; 2022 Sep-Oct 01; 28(5):491-495. PubMed ID: 35834786
[TBL] [Abstract][Full Text] [Related]
3. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
[TBL] [Abstract][Full Text] [Related]
4. Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Induced Seroprevalence: A Nationwide Blood Donor Study-United States, July 2020-June 2021.
Li Z; Lewis B; Berney K; Hallisey E; Williams AM; Whiteman A; Rivera-González LO; Clarke KEN; Clayton HB; Tincher T; Opsomer JD; Busch MP; Gundlapalli AV; Jones JM
Clin Infect Dis; 2022 Aug; 75(1):e133-e143. PubMed ID: 35137014
[TBL] [Abstract][Full Text] [Related]
5. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia.
Krieger E; Sharashova E; Kudryavtsev AV; Samodova O; Kontsevaya A; Brenn T; Postoev V
Infect Dis (Lond); 2023 May; 55(5):316-327. PubMed ID: 36919829
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
8. The Differential Impact of Reopening States With and Without COVID-19 Face Mask Mandates on County-Level Consumer Spending.
Dunphy C; Miller GF; Sunshine G; McCord R; Howard-Williams M; Proia K; Stephens J
Public Health Rep; 2022; 137(5):1000-1006. PubMed ID: 35792601
[TBL] [Abstract][Full Text] [Related]
9. Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
Lim T; Delorey M; Bestul N; Johannson MA; Reed C; Hall AJ; Fry AM; Edens C; Semenova V; Li H; Browning P; Desai R; Epperson M; Jia T; Thornburg NJ; Schiffer J; Havers FP
Clin Infect Dis; 2021 Nov; 73(10):1831-1839. PubMed ID: 33639620
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
11. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.
Reedman CN; Drews SJ; Yi QL; Pambrun C; O'Brien SF
Microbiol Spectr; 2022 Apr; 10(2):e0033922. PubMed ID: 35412385
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between COVID-19 Infection and Risk Perception, Knowledge, Attitude, and Four Nonpharmaceutical Interventions During the Late Period of the COVID-19 Epidemic in China: Online Cross-Sectional Survey of 8158 Adults.
Xu H; Gan Y; Zheng D; Wu B; Zhu X; Xu C; Liu C; Tao Z; Hu Y; Chen M; Li M; Lu Z; Chen J
J Med Internet Res; 2020 Nov; 22(11):e21372. PubMed ID: 33108317
[TBL] [Abstract][Full Text] [Related]
13. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
14. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.
Takayama Y; Komatsu T; Wada T; Nihonyanagi S; Hoshiyama T; Moriya T; Shimamura S; Kajigaya N; Naito M; Takeuchi O; Bando Y; Watanabe M; Iwamura M; Hanaki H
J Nippon Med Sch; 2022 Nov; 89(5):513-519. PubMed ID: 35644553
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021.
Giuliano AR; Pilon-Thomas S; Schell MJ; Abrahamsen M; Islam JY; Isaacs-Soriano K; Kennedy K; Dukes CW; Whiting J; Rathwell J; Hensel JA; Mangual LN; Schonbrunn E; Bikowitz M; Grassie D; Yang Y
Emerg Infect Dis; 2022 Mar; 28(3):556-563. PubMed ID: 35081021
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
[TBL] [Abstract][Full Text] [Related]
17. The Association Between State-Issued Mask Mandates and County COVID-19 Hospitalization Rates.
Dunphy C; Joo H; Sapiano MRP; Howard-Williams M; McCord R; Sunshine G; Kao SY; Guy GP; Weber R; Gakh M; Ekwueme DU
J Public Health Manag Pract; 2022 Nov-Dec 01; 28(6):712-719. PubMed ID: 36194816
[TBL] [Abstract][Full Text] [Related]
18. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
